Received Feb 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
Itchy rash down the arm; This non-serious case was reported by a consumer and described the occurrence of itchy rash in a 79-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. Concomitant products included sutimlimab. On 13-JAN-2026, the patient received Bexsero. On 14-JAN-2026, 1 days after receiving Bexsero, the patient experienced itchy rash (Verbatim: Itchy rash down the arm). On 22-JAN-2026, the outcome of the itchy rash was resolved (duration 8 days). It was unknown if the reporter considered the itchy rash to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the itchy rash to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-FEB-2026 The batch number was not provided, and we are unable to contact the reporter.
SUTIMLIMAB